Launching Soon Website for Jivi Apr 23, 2018Apr 25, 2018 Brand: Jivi (antihemophilic factor (recombinant) PEGylated), Intravenous Infusion Parent Company: Bayer Drug Type: Prescription Drug Category: Hematology Campaign: Coming Soon Targeting: HCPs, Patients, Caregivers Patient Website: https://www.jivi.com/ HCP Website: https://www.jivi.com/ Desktop Mobile Register